The 2026 Horizon Europe arbitrage: the deals Europe already paid for

Patrick Halford
Feb 1
3 min read

Europe has already funded a huge pipeline of deep-tech, dual-use capability, and AI-relevant IP. Real prototypes. Real methods. Real teams. The problem is it’s trapped inside a slow machine.

That’s the arbitrage in 2026: a 3–4 year grant clock colliding with a 3‑month AI clock. Projects designed for a long arc can now hit key technical milestones 18–24 months early. The assets are ready. The structure isn’t. And because Brussels won’t reform fast, the gap persists through 2027–2028 and into the successor programme. That persistence is the opportunity.

Where the value hides

1) Live projects finishing early

When AI accelerates the core work, the remaining time gets soaked up by governance: meetings, reporting, “extra activities.” Meanwhile, usable components sit idle.

Move: identify projects where the real work is done, extract what’s usable (software, data, designs, methods), and package it while the consortium continues in the background.

2) The rejected 80%

Only 10–25% of proposals get funded. Many rejections are still above threshold—good ideas that lost on budget limits, timing, or geography. That’s screened deal flow disguised as admin waste.

Move: re-evaluate rejected concepts against current AI capability. What was impractical 18 months ago may now be buildable in weeks.

3) IP trapped in consortium structures

IP is split across partners; rights are messy; nobody has clear authority to carve out a module and run.

Move: do the unglamorous work—clarify ownership, slice clean pieces, and structure licensing, spin-outs, JVs, or acqui-hires.

4) Talent ready to move

Consortia have already proven who can deliver. But teams wait for “exploitation” at the end—by then the market has moved and the team may have scattered.

Move: connect teams to buyers and capital mid‑project while they’re still intact.

What private capital can do that the system can’t

This isn’t charity. It’s timing and pricing:

Lower entry cost: core technology has already been built and validated with grant funding.
Better signal: delivery under EU scrutiny beats a pitch deck.
Regulatory head starts: standards and compliance work is often already underway.
Timing advantage: assets can be investable well before the project “ends.”

The missing layer: brokerage

The market doesn’t lack technology. It lacks connective tissue: a brokerage layer that translates public R&D progress into investable assets. That layer does five things well:

monitors project progress against AI acceleration curves
identifies carve‑outs that won’t blow up the consortium
resolves IP and ownership friction
packages assets into investable structures
matches the right investors (VC vs PE vs strategics)

Do this repeatedly and the path is predictable: brokerage → co‑investment → principal investor → platform. The bridge builder ends up owning the toll road.

The warning shot for Horizon advisory firms

AI will squeeze proposal drafting, compliance, and reporting margins. Volume won’t save you.

But advisory firms are sitting on three assets markets will pay for:

programme knowledge (what gets funded and why)
network maps (who works with whom; who delivers)
near‑miss memory (strong proposals that narrowly missed funding)

That is proprietary origination intelligence—if you choose to sell it as such.

The move in 2026

Stop treating Horizon Europe like “innovation theatre.” Treat it like a sourcing channel.

Corporates: productise in parallel—don’t wait for the exploitation work package.
Investors: build themed pipelines from funded and rejected pools; consider backing the brokerage layer, not just deals.
Universities: keep a live spin‑out list from funded and rejected proposals; staff tech transfer with people who can talk to capital.

The window is open now. Competition will catch up. But the gap is structural, the assets are real, and the assumptions you’re using today will be wrong by mid‑2026.

Two questions to end on:

What assets in my current projects could I move on now—without waiting for project end?
Who is building the bridge between slow public R&D and fast private deployment—and why isn’t it me?